drug
EN-374
Phase 2updated 3mo agoby Ensoma Inc
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying EN-374
News(1)
- Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapyBoston biotech Ensoma is doubling down on its lead gene therapy for a rare immune disease, laying off another round of employees after previously halving its workforce last November.fiercebiotech · 7d ago
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that